Targeting PRAS40 directly or suppressing PRAS40 expression indirectly through enhancement of miR-142-3p impairs the formation of TSC-associated renal cysts, which may provide promising therapeutic approaches for diseases with hyperactivated mTOR signaling. This evidence concerns the gene AKT1S1 and Renal cyst.